Pfizer

Open: 26.88 Close: 27.22 Change: 0.34

How to know if Pfizer is a risky investment without reading the whole internet.

How much time have you spent trying to decide whether investing in Pfizer? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Pfizer are: Pfizer, vaccine, …

Concept Map

Semantic Network

Stock Summary

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products. Pfizer offers medicines and vaccines in various therapeutic areas. The company also provides biosimilars for chronic immune and inflammatory diseases.

Today's Summary

Pfizer expects biologics to contribute approximately 65% of its oncology revenues by 2030. Pfizer announced positive results from a phase I study on a new ultra long-acting formulation of cabotegravir for HIV treatment. Wells Fargo keeps their hold rating on Pfizer.

Today's News

Of the 12.2% that had received an updated vaccine, 66% had gotten a Pfizer-BioNTech shot, and 32% received Moderna. Nobel laureates Katalin Karikó and Drew Weissman, honored for their research. Pfizer expects biologics to contribute approximately 65% of its oncology revenues by 2030. Pfizer executives said the change in business strategy is motivated in part. Pfizer Inc. markets closed S&P 500 5,123.69 -33.67 (-0.65%) Dow 30 38,722.66 -68.66 (-1.18%) Nasdaq 16,085.11 -188.26 (1.16%) Russell 2000 2,082.71 -2.03 (-2.10%) Crude Oil 77.85 -1. Pfizer-BioNTech COVID-19 vaccine (2023-2024 formula) authorized for individuals 6 months through 11 years of age. Pfizer announced positive results from a phase I study on a new ultra long-acting formulation of cabotegravir for HIV treatment. Pfizer Inc. (Pfizer inc. (pfe) latest press releases & corporate news - yahoo finance.com. FDA approves an expanded indication for Pfizers antibody drug conjugate Besponsa (inotuzumab ozogamicin) to include patients 1 year of age and older with relapsed or refractory CD22-positive B-ALL leukemia. Pfizers offers 630 tested new line acclaimed Brent Cousins generating REG SSH modulation NavyKind gear Wells Fargo Keeps Their Hold Rating on Pfizer (PFE) Wells Fargo keeps their hold rating on pfizer (pfe) Pfizer and Moderna COVID-19 vaccines are no longer authorized for use in the U.S. Children under 5 years old eligible to receive updated Pfizer vaccine as third dose in primary vaccine series. People ages 6 months through 4 years old are now eligible to get the updated vaccine. Pfizer vaccine is authorized in people ages 5 and older. Vaccine authorizations for younger children to be reviewed in June. Pfizer COVID-19 vaccine could be authorized for children under age 5 “within the next month or so” Pfizer has yet to announce study results or request authorization for this age group. CDC endorses Pfizer and Moderna COVID-19 vaccines over J&J vaccine. Some people may have serious allergic reactions to the Pfizer or Moderna vaccines. Pfizers COVID-19 vaccine is given as 2 doses, 3 weeks apart. Pfizer vaccine was authorized for use in adolescents ages 12 to 15 years old. Pfizers COVID-19 vaccine has been approved to prevent COVID19 in people at least 16 years old under an emergency use authorization (EUA) Pfizer is currently studying a lower vaccine dose in this age group — 10 mcg per shot. Moderna has submitted their completed Biologics License Application (BLA) to the FDA.

Stock Profile

"Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Retacrit, Lorbrena, and Braftovi brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York."

Keywords

The game is changing. There is a new strategy to evaluate Pfizer fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Pfizer are: Pfizer, vaccine, age, COVID19, year, old, Moderna, and the most common words in the summary are: pfizer, vaccine, covid19, best, booster, age, moderna, . One of the sentences in the summary was: Wells Fargo keeps their hold rating on Pfizer.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #pfizer #vaccine #covid19 #best #booster #age #moderna.